Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEOLUS: Dupilumab in COPD
NCT07053423Phase 4Recruiting
- Sponsor
- Sanofi
- Start
- Sep 2025
- Primary completion
- Dec 2028
- Modality
- Monoclonal Antibodies
- Countries
- 22
01
Overview
A Phase 4 trial of dupilumab in chronic obstructive pulmonary disease (COPD), sponsored by Sanofi. Started Sep 2025; status: recruiting.
02
Drugs
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07053423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07053423.